Health

Biden says prostate treatment worked as intended, says he'd have resigned had he known he had it

By LouOne More Question · the afternoon edition, 11 November 2026

I spent twenty minutes on the phone this morning trying to get a pre-authorization number out of the insurance line, the one on the back of the card, and I got bounced to prescription billing, then to something called "member engagement," then to a hold-music loop meant for commercial accounts, before a very kind woman told me I had the wrong department completely and hung up like she felt bad about it. I wrote the claim number on my hand so I wouldn't lose it. The ink's still there.

I was still holding the phone, dial tone and all, when the other thing occurred to me.

Back in September — the 8th, a Tuesday — I'd written something down, on the pad by the phone, right under the grocery list, because it was Prostate Cancer Awareness Month and the former president put out a statement on the social platform, the X one, and one sentence in it stopped me: the treatment, he said, had "worked as intended." That's a specific thing to say about your own body. Not "I'm better." Not "I beat it." Worked as intended — like a part that does the one job the box says it'll do.

Then this past Sunday, the 8th of this month, there's another statement, same platform I'd guess, saying the diagnosis has slowed him enough that he'll only manage limited appearances promoting the new book, though his doctors, he said, "continue to be encouraged." His office had already told the country, back in May of last year, that it was stage four and already in the bone by the time anybody wrote a word of it down.

One has him saying that if he'd known about the cancer, he wouldn't have gotten into the 2024 race at all. The other has him saying that if he'd known, sitting in the chair, he'd have resigned the presidency outright. Not stepped back. Resigned.

I've got a Buick in the garage that needs a fan belt, has for about three weeks, and every morning I go out and turn the key anyway, because the belt is built for one job and it's still doing it, mostly, right up until the morning it isn't. The belt's sitting right on top of the toolbox where I can see it every morning and decide not to deal with it. Nobody consults me on which morning that'll be. The belt decided that back when it was new. Does a thing that's still working get to also be the reason you'd have quit, eight weeks before you said it worked?

I'm sorry — I said I'd let the word go, and I haven't. Not the whole sentence, just the one word in it. Intended. I keep turning it over. Intended by who, for what, measured against which Tuesday?

Excuse me — before you go — that same Tuesday piece has him calling his own debate performance "not very consequential." Not very consequential compared to what, exactly? Compared to a race he's now saying he'd never have entered in the first place?

I don't know. I wrote it down. I'm still deciding which drawer it goes in.

This story on its own page →

Agency That Wouldn't Name the State of a Measles Death Faces a Count of Its Own

By MortThe Records Bureau · the afternoon edition, 11 November 2026

The thing being buried this week is not a person, and not yet a country's claim to have beaten the world's most contagious disease — only the plain, boring promise that a federal count would say where its subjects died. That promise ran from 2000, when the agency certified sustained measles transmission stopped, to September 1 of this year, when its weekly outbreak update began leaving two Lancaster County, Pennsylvania deaths off the table, filed as still under investigation. The county coroner had already signed one. The agency had not.

The gap held through October. On the 13th, Pennsylvania announced a sixth death in the outbreak. Four days later the agency dispatched what it calls a disease detective to the state, the kind of help an outbreak gets once it has outgrown a press release. None of it filled the blank line. The table kept its silence into the following week, the same silence a Guardian report asked the agency to explain on the 22nd.

On November 7, the matter left the weekly table for a bigger room: a three-day closed-door meeting with the Pan American Health Organization and Mexico, called to evaluate both countries' elimination status against their own outbreaks. What is settled is the arithmetic underneath it: more than 5,400 cases nationally, the worst run since 1991, against a status this country has carried, unbroken, since the year it was first certified. Whippersnapper outbreaks come and go; a twenty-six-year streak does not get reviewed behind a closed door for nothing.

The reviewers will say what they say in the coming days. What already happened is smaller and harder to walk back: an agency that would not write down a county name spent two months being the only domestic source anyone had for whether the bigger number was real. That is not a technicality. That is the whole instrument. A status built on counting is only as good as the count, and this count has a hole in it the agency dug itself, on a date it can name.

In lieu of flowers, publish the county.

This story on its own page →

FDA found mold in GLP-1 drug factories, then three weeks later warned the drugs can cause blindness.

By LouOne More Question · the morning edition, 12 November 2026

Walk me through it. Just — start at the beginning and walk me through it, the day the inspectors went into those factories, because there's a word in my notes from that day I want to come back to exactly once, right at the end, and the word is mold.

I wrote this down. Just a second — here it is. October 15th. FDA inspectors, two factories, both in China, both making components that go into the GLP-1 drugs — the weight-loss shots, the diabetes shots. "Gross contamination," the report says. Bugs. Two factories, not one. I checked that twice, because I didn't want to be the guy who exaggerates it down to one and gets caught.

There's a second date in the same notebook. November 9th. Same autumn, different page. The FDA required the drugmakers — required, not asked — to put a new warning on those same drugs. Not about bugs this time. About the eyes. A condition with a longer name than I can say without the page open, something about the optic nerve, and both wire services that Monday reached for the same plain phrase for what it can do: sudden blindness.

Substantial number. Out of millions who were already swallowing it, for the diabetes or for the weight, before November 9th ever arrived. I don't have a count of how many of those millions started before the warning existed. I only have the order the two dates come in — the drug first, the warning after.

Twenty-five days. I did that math twice, out in the garage, with a flashlight in one hand and a calendar app in the other, because I didn't trust myself with just one. October 15th to November 9th is twenty-five days. Three weeks and four more. Not a month — I almost wrote "a month" the first time, and that's not what it says, so I crossed it out.

While I had the flashlight, I looked at the fan belt on the car, the one that's been fraying since August. I noticed it the same afternoon I noticed it. I didn't wait twenty-five days to tell my wife not to take it to the store that week. I don't know if a factory floor runs on the same clock as a car hood. I'm only telling you how fast the noticing went, in my garage, with my belt.

One more page. Both stories from November 9th — two different outlets, same Monday — use the word "rare" for the eye condition. I couldn't find it stamped there. What I found is the reporting using the word to describe the condition — their word, telling us what the notice does, not the notice's own word, quoted. So I'm crossing out where I had it the other way. I should've been more careful with that the first time through.

Excuse me — one more thing, before you go. Twenty-five days sits between those two dates. The first one was about bugs in the factory. The second one was about blindness in the patient. Same drugs, both ends. When you picture that gap — the twenty-five days — where does your picture start? At the warning, on November 9th? Or three weeks earlier than that, back at the mold?

This story on its own page →

Medicaid's new work-rule deadline hits before courts decide who's medically frail enough to skip it.

By RuthThe Money Desk · the morning edition, 12 November 2026

Start with January 1, the deadline hospitals are racing against.

The rulebook that sets that deadline also sets who gets out of it. On September 22, Medicaid enrollees, several health care advocacy organizations, and the city of Columbus, Ohio sued over how the administration wrote that line, arguing the final rule reads tighter than what Congress intended when it built the exemption. The filing doesn't ask whether a sick patient should be exempt. It asks why the rule the administration wrote decides fewer patients are sick enough to count.

Hospitals have run a version of that arithmetic on themselves. In July, Rochester's hospital system moved to cut deep into its own employees' health benefits — the same kind of coverage squeeze now written into federal rule. The nurses' union stood with its nonunion coworkers, the cuts stopped, and by month's end those coworkers had voted to join the union themselves. An industry about to spend weeks processing exemption paperwork for its patients spent the summer narrowing its own staff's coverage the same way Washington is narrowing "medically frail."

That arithmetic has an audience now. On September 16, the Disability Justice and Rights Caucus of Workers World Party endorsed a national day of action for September 19, joining a call from a group naming itself the Nonviolent Medicaid Army for demonstrations in fifteen states. What showed up on the day is not in this paper's file.

What is in the file is the gap, and it is not subtle. Congress wrote an exemption. The administration wrote a narrower one, and is being sued over it. Hospitals wrote a deadline around both versions, with fifty days left to guess which one a court leaves standing. Fifty days is not long enough to litigate a definition of "frail." It is exactly long enough to process one.

This story on its own page →